Improvements in quality of life measures · patients with established cardiomyopathy in DMD
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Adverse events · patients with established cardiomyopathy in DMD
1 finding from 1 review
Clinical cure according to criteria established by study authors Severe PID · women with PID
Regimens containing quinolone showed no clear difference in clinical cure according to criteria established by study authors… compared with regimens containing cephalosporins (low certainty).
1 finding from 1 review
RR 1.06 [0.91, 1.23]
Studies not reported
Low
Adverse events: any antibiotic‐related adverse event leading to discontinuation of therapy · women with PID
It is very uncertain whether regimens containing quinolone changes adverse events: any antibiotic‐related adverse event leading to… compared with regimens containing cephalosporins (very low certainty).
1 finding from 1 review
RR 2.24 [0.52, 9.72]
Studies not reported
Very low
Microbiological clearance · women with PID
It is very uncertain whether regimens containing quinolone changes microbiological clearance compared with regimens containing cephalosporins (very low certainty).
1 finding from 1 review
RR 0.95 [0.84, 1.08]
Studies not reported
Very low
Laparoscopic evidence of resolution of PID based on physician opinion · women with PID
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Length of stay · women with PID
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Fertility outcome · women with PID
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Clinical cure according to criteria established by study authors Mild‐moderate PID · women with PID
Regimens containing quinolone showed no clear difference in clinical cure according to criteria established by study authors… compared with regimens containing cephalosporins (low certainty).
1 finding from 1 review
RR 1.05 [0.98, 1.14]
Studies not reported
Low
Confirmed SARS‐CoV‐2 infection
1 finding from 1 review
Confirmed symptomatic COVID‐19b
1 finding from 1 review
Severe or critical COVID‐19
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
All‐cause mortality
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Systemic reactogenicity events
BBIBP‐CorV – Sinopharm‐Beijing showed no clear difference in systemic reactogenicity eventse compared with placebo (moderate certainty).
1 finding from 1 review
Any adverse eventh
1 finding from 1 review
Serious adverse eventsk
BBIBP‐CorV – Sinopharm‐Beijing showed no clear difference in serious adverse eventsk compared with placebo (low certainty).
1 finding from 1 review
Local reactogenicity events
1 finding from 1 review
Treatment failure ‐ lincosamides versus cephalosporins · women with postpartum endometritis
Clindamycin plus aminoglycoside may leads to lower treatment failure ‐ lincosamides versus cephalosporins compared with any other regimen (low certainty).
1 finding from 1 review
Treatment failure ‐ lincosamides versus penicillins · women with postpartum endometritis
Clindamycin plus aminoglycoside may leads to lower treatment failure ‐ lincosamides versus penicillins compared with any other regimen (low certainty).
1 finding from 1 review
Severe complication ‐ lincosamides versus cephalosporins · women with postpartum endometritis
It is very uncertain whether clindamycin plus aminoglycoside changes severe complication ‐ lincosamides versus cephalosporins compared with any other regimen (very low certainty).
1 finding from 1 review